• LAST PRICE
    0.4201
  • TODAY'S CHANGE (%)
    Trending Up0.0460 (12.2962%)
  • Bid / Lots
    0.4100/ 48
  • Ask / Lots
    0.4300/ 2
  • Open / Previous Close
    0.3600 / 0.3741
  • Day Range
    Low 0.3600
    High 0.4500
  • 52 Week Range
    Low 0.1328
    High 2.8800
  • Volume
    322,421
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.3741
TimeVolumeGCTK
09:32 ET91750.381001
09:36 ET8700.376591
09:39 ET1000.3801
09:50 ET15220.3802
10:01 ET11840.3801
10:15 ET541000.39
10:17 ET5000.38
10:24 ET239420.41
10:26 ET62670.44
10:28 ET874310.4019
10:30 ET1000.3936
10:32 ET2750.4132
10:35 ET18100.41
10:37 ET18000.394
10:39 ET3820.4
10:42 ET3000.4
11:02 ET2500.42
11:09 ET22280.42
11:15 ET5500.41
11:24 ET115000.41
11:33 ET15250.41
11:40 ET34820.41
11:47 ET9000.41
11:56 ET10000.4102
12:18 ET2000.42
12:20 ET10300.42
12:23 ET5000.42
12:32 ET100900.4
02:47 ET25160.41
03:05 ET23000.41
03:07 ET26100.41
03:12 ET1000.41
03:30 ET59000.4102
03:34 ET88410.4102
03:36 ET1000.4119
03:38 ET12000.4135
03:43 ET8480.4131
03:48 ET16540.4102
03:50 ET151150.4244
03:52 ET90500.418
03:57 ET381640.4201
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGCTK
GlucoTrack Inc
10.0M
-1.2x
---
United StatesPRTG
Portage Biotech Inc
9.9M
-0.1x
---
United StatesHEPA
Hepion Pharmaceuticals Inc
9.7M
-0.2x
---
United StatesCHRO
Chromocell Therapeutics Corp
10.6M
-2.8x
---
United StatesVIRI
Virios Therapeutics Inc
9.2M
-1.8x
---
United StatesCMMB
Chemomab Therapeutics Ltd
10.8M
0.0x
---
As of 2024-04-12

Company Information

GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. It is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an approximately two-year implant longevity without the requirement for any wearable components. The CBGM utilizes an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood vessel. This facilitates continuous blood glucose measurements with zero lag time. The Company is also developing the Glucotrack CBGM a companion mobile application and a cloud-based solution to provide real time, data-driven personalized tools to effectively help a user manage their diabetes and assist healthcare providers with making treatment decisions.

Contact Information

Headquarters
301 Rte 17 North, Ste. 800RUTHERFORD, NJ, United States 07070
Phone
201-842-7715
Fax
302-655-5049

Executives

Chief Executive Officer
Paul Goode
Chief Financial Officer
James Cardwell
Vice President - Engineering
James Thrower
Director
Erin Carter
Director
Andrew Sycoff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.0M
Revenue (TTM)
$0.00
Shares Outstanding
26.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.28
EPS
$-0.34
Book Value
$0.15
P/E Ratio
-1.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.